Boundless Bio, Inc. Common Stock
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $54,796,000.
Profit Margin
| 2016 | 0 | -59.66M | |
|---|---|---|---|
| 2017 | 0 | -90.23M | |
| 2018 | 0 | -128.82M | |
| 2021 | 0 | -25.21M | |
| 2022 | 0 | -45.90M | |
| 2023 | 0 | -49.43M |
BOLD Income Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 957K | 942K | 682K | 0 | 0 | 0 |
Gross profit | -957K | -942K | -682K | 0 | 0 | 0 |
Operating exp. | ||||||
Research and development | 41.68M | 37.15M | 19.27M | 104.37M | 75.90M | 48.77M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 54.79M | 46.46M | 25.30M | 134.37M | 93.17M | 60.04M |
Operating income | -54.79M | -46.46M | -25.30M | -134.37M | -93.17M | -60.04M |
Other income (expenses), net | 5.36M | -100K | -5K | 5.55M | 693K | 378K |
Income before tax | -49.43M | -45.90M | -25.21M | -128.82M | -92.48M | -59.66M |
Income tax expense | 0 | -668K | -96K | 5.55M | -2.24M | 378K |
Net income | -49.43M | -45.90M | -25.21M | -128.82M | -90.23M | -59.66M |
Earnings per share | ||||||
Basic EPS | -2.22 | -2.06 | -1.13 | -2.93 | -2.05 | -1.36 |
Diluted EPS | -2.22 | -2.06 | -1.13 | -2.93 | -3.4 | -5.59 |
| Data source | Data source | Data source |